|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate investments, at cost: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Acquired intangible assets | ||||||||||||||||||||
| Total real estate investments, at cost | ||||||||||||||||||||
| Less accumulated depreciation and amortization | ||||||||||||||||||||
| Total real estate investments, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Contract asset | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Derivative asset, at fair value | ||||||||||||||||||||
| Straight-line rent receivable | ||||||||||||||||||||
| Deferred leasing costs, net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Mortgage notes payable, net | ||||||||||||||||||||
| Debt associated with property in receivership | ||||||||||||||||||||
| Accrued interest associated with property in receivership | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities (including amounts due to/(from) related parties of $68 and $(280) at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Note payable to related parties | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Below-market lease liabilities, net | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 50,000,000 shares authorized, none issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.01 par value, 300,000,000 shares authorized, 3,163,632 and 2,692,941 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
Loading...
